Autism Research, published by WILEY, is a premier academic journal dedicated to advancing the understanding of autism spectrum disorders (ASD) through high-quality research and clinical studies. With the ISSN 1939-3792 and E-ISSN 1939-3806, this journal has been integral to the field since its inception in 2008 and has been consistently ranked in the Q1 quartile across categories such as Genetics (clinical), Neurology (clinical), and various facets of Neuroscience. Holding prominent Scopus ranks, including #18 in Genetics (clinical) and #26 in General Neuroscience, Autism Research provides a vital platform for researchers, clinicians, and students alike to disseminate innovative findings and foster collaborations aimed at improving diagnosis and treatment strategies for individuals with autism. While not an open access journal, it offers a blend of insightful articles and impactful research that is essential for professionals seeking to stay at the forefront of this rapidly evolving field.

Psychiatry and Clinical Psychopharmacology, an open-access journal published by AVES since 2017, is dedicated to advancing the fields of psychiatric medicine and psychopharmacology. With an ISSN of 2475-0573 and an E-ISSN of 2475-0581, this journal aims to provide a platform for disseminating innovative research and clinical findings relevant to mental health professionals and researchers. Although it currently holds a Q3 ranking in Pharmacology (medical) and a Q4 ranking in Psychiatry and Mental Health according to the 2023 category quartiles, the journal has established itself as a significant contributor to evolving discussions in these critical fields. Based in the United Kingdom, the journal encompasses diverse topics, ranging from pharmacological treatments to novel therapeutic approaches in psychiatry, thereby appealing to a broad audience of clinicians, scientists, and students. The open-access model ensures that all research is readily available, fostering an environment of collaboration and knowledge-sharing as the journal converges until 2024 to encompass the latest advancements in both pharmacology and clinical psychopharmacology.

Review Journal of Autism and Developmental Disorders, published by Springer Heidelberg, stands as a leading platform for the dissemination of groundbreaking research in the realm of autism and developmental disorders. With an ISSN of 2195-7177 and an E-ISSN of 2195-7185, this journal not only showcases high-quality research but also emphasizes the crucial intersections between behavioral neuroscience, cognitive neuroscience, developmental neuroscience, and psychiatry. Notably, the journal has achieved a prestigious Q1 ranking across these categories, reflecting its impact and relevance; it ranks 10th in behavioral neuroscience and 5th in developmental neuroscience within Scopus metrics. Spanning from 2014 to 2024, the journal is dedicated to fostering a deeper understanding of autism spectrum disorders and related conditions, making it indispensable for researchers, clinicians, and students alike. While it operates under a traditional access model, the quality of the peer-reviewed articles ensures that it remains a valuable resource in the academic community.

CoDAS, an esteemed academic journal published by the SOC BRASILEIRA FONOAUDIOLOGIA, serves as a leading platform for interdisciplinary research within the realms of linguistics, speech, and hearing sciences. Established as an Open Access journal in 2013, it ensures broad dissemination and accessibility of scholarly work, significantly benefitting researchers, clinicians, and students alike. Based in Brazil, CoDAS has garnered credibility with its impressive Q2 ranking in Linguistics and Language, as well as its rankings in Otorhinolaryngology and Speech and Hearing categories, reflecting its substantial contribution to these fields. The journal's impact is underscored by its robust Scopus rankings, including the 67th percentile in Language and Linguistics. With a commitment to fostering innovative research and bridging gaps between theory and practice, CoDAS continues to play a vital role in advancing knowledge and clinical practices in communication disorders and auditory sciences.

Developmental Neurorehabilitation is an esteemed journal published by Taylor & Francis Inc, dedicated to advancing the field of developmental neuroscience and rehabilitation. With an ISSN of 1751-8423 and an E-ISSN of 1751-8431, this journal serves as a vital resource for researchers, clinicians, and students interested in innovative therapeutic approaches and rehabilitation techniques for children and adolescents. Since its inception in 1997, Developmental Neurorehabilitation has focused on disseminating high-quality research, contributing to a deeper understanding of recovery processes in developmental disorders, and facilitating interdisciplinary dialogue among professionals. With its recognition in Q2 and Q3 quartiles across prominent categories such as Pediatrics and Rehabilitation, it stands out as a pivotal publication in its field, boasting Scopus rankings that reflect its significant impact—ranked #53 in Rehabilitation and #139 in Pediatrics, among others. While maintaining a commitment to quality research, the journal does not currently offer open access but remains accessible through institutional subscriptions, further enriching the academic landscape with critical insights into rehabilitation methodologies for developmental challenges and promoting better clinical practices to improve patient outcomes.

Advances in Neurodevelopmental Disorders is a leading peer-reviewed journal published by SpringerNature, focusing on the critical intersection of psychology and social sciences as they pertain to neurodevelopmental disorders. With its ISSN 2366-7532 and E-ISSN 2366-7540, this journal has carved out a significant niche since its inception in 2017, particularly recognized for its influence in academia, evident from its category quartiles in 2023, which rank it Q3 in Psychology and Q2 in Social Sciences. The journal is committed to disseminating innovative research and knowledge that advance our understanding of neurodevelopmental disorders, making it an essential resource for researchers, professionals, and students dedicated to this field. With increasing citations and a respectable Scopus ranking—#209 in Social Sciences and #46 in Psychology—the journal continues to foster interdisciplinary dialogue and scientific advancement. Based in the Netherlands and published out of London, it offers a platform for open access to significant findings and discussions related to neurodevelopmental challenges, addressing a vital area of health that impacts individuals and families worldwide.

JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, published by Lippincott Williams & Wilkins, stands as a pivotal platform for interdisciplinary research in the fields of pediatrics, psychology, and mental health. Established in 1980 and with a comprehensive coverage extending to 2024, this esteemed journal operates within the realms of developmental and educational psychology, medicine, and psychiatry, earning a commendable Q2 ranking in its respective categories as of 2023. Its overarching objective is to disseminate high-quality, peer-reviewed studies that address the intricate interplay between developmental milestones and behavioral health in children. Although it does not currently offer open access, the journal's influential presence in the scholarly community is underscored by its strategic positioning within the Scopus rankings, making it an invaluable resource for researchers, practitioners, and students committed to advancing the health and well-being of children and adolescents.

Molecular Autism, published by BMC in the United Kingdom, is a premier open-access journal dedicated to publishing high-quality research on the molecular and genetic factors contributing to autism spectrum disorders. Since its inception in 2010, the journal has established itself as a vital resource for researchers and clinicians, offering insights into the developmental biology, neuroscience, and psychiatric dimensions of autism. With an impressive impact factor and rankings placing it in the Q1 category across multiple relevant fields such as Developmental Biology, Developmental Neuroscience, Molecular Biology, and Psychiatry and Mental Health, it serves as a critical platform for the dissemination of innovative research and interdisciplinary collaboration. The journal encourages open dialogue through its commitment to making research freely accessible, thereby advancing knowledge and fostering advances in the understanding of autism. By bridging diverse disciplines and engaging with cutting-edge research, Molecular Autism aims to enhance our understanding of autism's complexities and inform future therapeutic approaches.

The INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE is a critical platform for disseminating cutting-edge research in the field of developmental biology and neuroscience. Published by WILEY, this esteemed journal has been contributing to the academic community since its inception in 1983, and continues to serve as a vital resource through to 2024. With an impact factor that reflects its influence in the field—ranking in Q3 for both Developmental Biology and Developmental Neuroscience—this journal presents an opportunity for researchers, professionals, and students alike to engage with pioneering studies and extend their understanding of complex developmental processes. Although not open access, the journal provides an essential repository of knowledge for those seeking to explore the nuances of neurological development and related disciplines. It actively supports academic discourse and research dissemination, thereby playing a significant role in advancing our collective understanding of developmental neuroscience.

BEHAVIOR MODIFICATION, published by SAGE PUBLICATIONS INC, is a prestigious journal dedicated to advancing the study and practice of behavior modification across various disciplines. With a robust ISSN of 0145-4455 and an E-ISSN of 1552-4167, this journal has established itself as a vital resource for researchers and practitioners since its inception in 1977. Recognized for its academic rigor, it is classified in the Q1 quartile for Arts and Humanities and Q2 in Clinical Psychology, as well as Developmental and Educational Psychology for 2023, showcasing its influence and relevance in these fields. The journal's Scopus rankings further exhibit its high standing, with 90th percentile in Arts and Humanities and 75th percentile in both development and clinical psychology categories. Although it is not an open-access journal, it provides essential insights and comprehensive research aimed at promoting evidence-based practices and innovative interventions in behavior modification. With a commitment to fostering interdisciplinary collaboration, BEHAVIOR MODIFICATION serves as an essential platform for researchers, professionals, and students seeking to enhance their understanding of behavioral principles to impact individual lives positively.